Insider · CIK 0001232506

Savage Robert G.

Reports to the SEC for 9 companies · MIAMI, FL

sec.gov

Transactions

Companies

Filings

CIK

0001232506

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-01	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director	AAward	+21K sh	$1.20	+$25.2K	21,022
2020-04-01	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director	AAward	+66.1K sh	$1.20	+$79.3K	66,071
2019-05-14	HUMANIGEN, INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100K sh	—	—	615,877
2019-05-14	HUMANIGEN, INCA Award	Director	AAward	+100K sh	$0.67	+$66.5K	199,869
2019-03-29	HUMANIGEN, INCA Award	Director	AAward	+13.7K sh	$1.35	+$18.5K	99,869
2019-01-03	HUMANIGEN, INCA Award	Director	AAward	+20.9K sh	$0.74	+$15.5K	86,165
2018-09-28	HUMANIGEN, INCA Award	Director	AAward	+24.2K sh	$0.64	+$15.5K	65,219
2018-08-07	HUMANIGEN, INCA Award	Director	AAward	+31K sh	$0.50	+$15.5K	41,000
2018-03-09	HUMANIGEN, INCStock Option (Right to Buy)A Award	Director	AAward	+716K sh	—	—	715,877
2016-10-17	Assertio Therapeutics, IncStock OptionA Award	Director	AAward	+18.5K sh	—	—	18,485
2016-05-26	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director	AAward	+9,700 sh	—	—	9,700
2016-05-26	MEDICINES CO /DEA Award	Director	AAward	+3,426 sh	—	—	31,146
2016-05-24	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$18.60	+$186K	37,720
2016-05-24	MEDICINES CO /DES Sale	Director	SSale	−10K sh	$36.95	−$370K	27,720
2016-05-24	MEDICINES CO /DEStock Option (right-to-buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2015-11-13	MEDICINES CO /DEStock Option (right-to-buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	10,000
2015-11-13	MEDICINES CO /DES Sale	Director	SSale	−5,000 sh	$39.34	−$197K	27,720
2015-11-13	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$18.60	+$93K	32,720
2015-05-28	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director	AAward	+11.5K sh	—	—	11,512
2015-05-28	MEDICINES CO /DEA Award	Director	AAward	+4,531 sh	—	—	27,720
2015-05-20	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$21.45	+$322K	38,189
2015-05-20	MEDICINES CO /DES Sale	Director	SSale	−15K sh	$26.78	−$402K	23,189
2015-05-20	MEDICINES CO /DEStock Option (right-to-buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2015-03-16	MEDICINES CO /DES Sale	Director	SSale	−7,500 sh	$28.98	−$217K	23,189
2013-08-12	IMMUNE PHARMACEUTICALS INCA Award	Director	AAward	+300K sh	—	—	475,300
2013-06-26	MergeWorthRx Corp.J Other	Director	JOther	+3,125 sh	—	—	34,375
2013-05-30	MEDICINES CO /DEOption (Right-to-buy)A Award	Director	AAward	+9,763 sh	—	—	9,763
2013-05-30	MEDICINES CO /DEA Award	Director	AAward	+3,849 sh	—	—	26,099
2013-03-13	MEDICINES CO /DES Sale	Director	SSale	−3,750 sh	$31.77	−$119K	22,250
2013-02-20	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$23.00	+$144K	32,250
2013-02-20	MEDICINES CO /DEOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	0
2013-02-20	MEDICINES CO /DES Sale	Director	SSale	−6,250 sh	$32.50	−$203K	26,000
2013-01-16	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$23.00	+$144K	32,250
2013-01-16	MEDICINES CO /DEOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2013-01-16	MEDICINES CO /DES Sale	Director	SSale	−6,250 sh	$30.00	−$188K	26,000
2013-01-16	MEDICINES CO /DEOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	6,250
2013-01-16	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$17.19	+$86K	31,000
2013-01-16	MEDICINES CO /DES Sale	Director	SSale	−5,000 sh	$30.00	−$150K	26,000
2013-01-08	MEDICINES CO /DEOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2013-01-08	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$17.19	+$86K	31,000
2013-01-08	MEDICINES CO /DES Sale	Director	SSale	−5,000 sh	$27.50	−$138K	26,000
2012-12-05	SAVIENT PHARMACEUTICALS INCOption to purchase Common Stock, $0.01 parA Award	Director	AAward	−21K sh	$1.14	−$24K	21,013
2012-12-05	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+16.1K sh	$1.14	+$18.4K	16,149
2012-08-06	MEDICINES CO /DEM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$17.19	+$172K	36,000
2012-08-06	MEDICINES CO /DES Sale	Director	SSale	−10K sh	$24.94	−$249K	26,000
2012-08-06	MEDICINES CO /DEOption (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	10,000
2012-06-21	IMMUNE PHARMACEUTICALS INCRestricted Stock UnitsA Award	Director	AAward	+60K sh	—	—	60,000
2012-05-22	MEDICINES CO /DEA Award	Director	AAward	+5,086 sh	—	—	26,000
2012-05-22	MEDICINES CO /DEOption (right to buy)A Award	Director	AAward	+12K sh	—	—	12,039
2011-06-14	IMMUNE PHARMACEUTICALS INCRestricted Stock UnitA Award	Director	AAward	+78.8K sh	—	—	78,750

Recent filings

Accepted (ET)
Apr 74/A
Savage Robert G.0001214659-20-003237
SEC(opens sec.gov)
Apr 24
Savage Robert G.0001214659-20-003156
SEC(opens sec.gov)
May 164
Savage Robert G.0001214659-19-003645
SEC(opens sec.gov)
Apr 24
Savage Robert G.0001214659-19-002486
SEC(opens sec.gov)
Jan 74
Savage Robert G.0001214659-19-000187
SEC(opens sec.gov)
Oct 24
Savage Robert G.0001214659-18-006287
SEC(opens sec.gov)
Aug 94
Savage Robert G.0001214659-18-005326
SEC(opens sec.gov)
Mar 134
Savage Robert G.0001214659-18-002134
SEC(opens sec.gov)
Oct 194
DEPOMED INC0001179110-16-030826
SEC(opens sec.gov)
May 314
MEDICINES CO /DE0001179110-16-025748
SEC(opens sec.gov)
May 264
MEDICINES CO /DE0001179110-16-025597
SEC(opens sec.gov)
Nov 164
MEDICINES CO /DE0001179110-15-014958
SEC(opens sec.gov)
Jun 14
MEDICINES CO /DE0001179110-15-008800
SEC(opens sec.gov)

Companies

Address

C/O NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH STREET

MIAMI, FL, 33186